The Syneos Health Podcast

Episode 028: World Cancer Day

February 01, 2019 Jeffrey Stewart / Bob Millham / Dave Querry
The Syneos Health Podcast
Episode 028: World Cancer Day
Chapters
The Syneos Health Podcast
Episode 028: World Cancer Day
Feb 01, 2019
Jeffrey Stewart / Bob Millham / Dave Querry

The treatment of cancer has undergone a sea change in the span of a generation.  In this two-part episode for World Cancer Day, we discuss the increasingly complex oncology landscape, from both a clinical and clinician perspective.  

First, Bob Millham, Executive Vice President of Clinical Development and head of our Oncology Center of Excellence, addresses the potential of clinical research in driving toward a world where cancer is treated more like a chronic condition than a death sentence – and the ongoing, critical importance of engaging patients in the process.

We then hear from Dave Querry, President of The Navicor Group, on the evolving role of the oncologist and how manufacturers need to think about engaging differently with this increasingly specialized practitioner.

Interested in reading more?  Follow these links for a deeper dive into a broad range of oncology topics from these and other Syneos Health experts:

Trends In Oncology Trial Terminations Due To Toxicity 

ESMO 2018 Congress: Some Good Answers and Quite a Few New Questions 

Pursuing Accelerated Approval in Oncology Indications

The Importance of Real World Evidence in Oncology

BIO18: Oncology Surplus Could Drive Down Values

A New Reality for Small Oncology Trial Sites: A Need to Adopt a Federated Approach?

Show Notes

The treatment of cancer has undergone a sea change in the span of a generation.  In this two-part episode for World Cancer Day, we discuss the increasingly complex oncology landscape, from both a clinical and clinician perspective.  

First, Bob Millham, Executive Vice President of Clinical Development and head of our Oncology Center of Excellence, addresses the potential of clinical research in driving toward a world where cancer is treated more like a chronic condition than a death sentence – and the ongoing, critical importance of engaging patients in the process.

We then hear from Dave Querry, President of The Navicor Group, on the evolving role of the oncologist and how manufacturers need to think about engaging differently with this increasingly specialized practitioner.

Interested in reading more?  Follow these links for a deeper dive into a broad range of oncology topics from these and other Syneos Health experts:

Trends In Oncology Trial Terminations Due To Toxicity 

ESMO 2018 Congress: Some Good Answers and Quite a Few New Questions 

Pursuing Accelerated Approval in Oncology Indications

The Importance of Real World Evidence in Oncology

BIO18: Oncology Surplus Could Drive Down Values

A New Reality for Small Oncology Trial Sites: A Need to Adopt a Federated Approach?